The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| ATEC | +105.57% | +40.69% | +7.07% | -82% |
| S&P | +11.09% | +81.2% | +12.62% | +422% |
Alphatec Holdings, Inc. engages in the design, development, and marketing of spinal fusion technology products and solutions for the treatment of spinal disorders. It offers intra-operative information and neuromonitoring technologies, access systems, interbody implants, fixation systems, and various biologics offerings. The company was founded on March 4, 2005 and is headquartered in Carlsbad, CA.
An HR executive at Alphatec sold 7.2% of his stake in the company for $2 million.
The spine surgery solutions company fell after pricing a $150 million public offering of common stock. Here's what investors need to know.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $196.50M | 30.4% |
| Gross Profit | $118.14M | 43.9% |
| Gross Margin | 60.12% | 5.7% |
| Market Cap | $2.15B | 175.5% |
| Market Cap / Employee | $2.48M | 0.0% |
| Employees | 867 | 3.3% |
| Net Income | -$28.58M | 27.9% |
| EBITDA | $10.97M | 225.3% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $155.74M | 92.3% |
| Accounts Receivable | $100.59M | 20.2% |
| Inventory | 166.9 | -8.9% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $520.05M | -6.3% |
| Short Term Debt | $71.11M | 709.9% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -20.21% | 4.9% |
| Return On Invested Capital | -33.90% | 3.7% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $4.81M | 122.7% |
| Operating Free Cash Flow | $14.04M | 362.8% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | -970.40 | -103.14 | -18.97 | 89.94 | -115.30% |
| Price to Sales | 2.17 | 2.32 | 2.44 | 3.02 | 117.07% |
| Price to Tangible Book Value | -7.61 | -8.18 | -6.44 | -14.54 | 215.35% |
| Price to Free Cash Flow TTM | 610.47 | - | |||
| Enterprise Value to EBITDA | -19178.64 | -184.22 | 234.27 | 242.63 | -262.84% |
| Free Cash Flow Yield | 0.2% | - | |||
| Return on Equity | -21137.1% | -291.7% | -376.9% | -540.4% | -45.99% |
| Total Debt | $609.94M | $581.28M | $586.63M | $591.15M | 4.84% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
